Impact of olfactory function on the trajectory of cognition, motor function, and quality of life in Parkinson's disease.

Background: Olfactory dysfunction in Parkinson's disease (PD) is associated with more severe phenotypes, but trajectories of cognitive function, disease severity, and subdomains of quality-of-life measurements in patients with distinct olfactory profiles remain underexplored. Objective: To analyze the influence of olfaction on trajectories of clinical parameters in patients with PD. Design: Retrospective cohort study. Subjects: From October 2016 to May 2021, the study tracked 58 participants over 3 years. Participants completed follow-up assessments using tools including the Chinese version of the University of Pennsylvania's Smell Identification Test (UPSIT), Montreal Cognitive Assessment (MoCA), Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale, and the Chinese translation of the 39-item Parkinson's Disease Questionnaire (PDQ-39). Methods: Participants were divided into anosmia (UPSIT < 19) and non-anosmia (UPSIT ≥ 19) groups based on initial scores. Generalized estimating equations and repeated measures correlations were used to examine longitudinal associations and correlations between olfaction and clinical parameters. Results: Divergent cognitive trajectories were observed between groups. The anosmia group exhibited a faster cognitive decline (adjusted B [beta coefficient] = -1.8, p = 0.012) according to the interaction effect of olfaction and time on the MoCA score. The anosmia group exhibited no longitudinal correlation between cognition and olfactory function but showed correlations with age (rrm [coefficient of repeated measures correlation] = -0.464, p = 0.004) and disease duration (rrm = -0.457, p = 0.005). The non-anosmia group's UPSIT scores decreased over time (B = -2.3, p = 0.005) alongside a significant correlation with motor function (rrm = -0.479, p = 0.006). Conclusion: The anosmia group's accelerated cognitive decline correlated with age and disease duration, but not olfactory function, suggesting a poor cognitive outcome in this population despite the lack of longitudinal correlation between cognition and olfaction. The non-anosmia group exhibited progressive olfactory degradation and notable correlations between motor function and UPSIT scores, implying pathological accumulation in the olfactory structure and basal ganglia.

Sequential change in olfaction and (non) motor symptoms: the difference between anosmia and non-anosmia in Parkinson's disease.

Introduction: Hyposmia is a common prodrome in patients with Parkinson's disease (PD). This study investigates whether olfactory changes in PD differ according to the degree of olfactory dysfunction and whether there are changes in motor and non-motor symptoms. Methods: The 129 subjects with PD were divided into two groups: anosmia and non-anosmia. All cases were reassessed within 1-3 years after the initial assessment. The assessment included the MDS-Unified PD Rating Scale (MDS-UPDRS), the University of Pennsylvania Smell Identification Test (UPSIT), Beck's Depression Inventory-II (BDI-II), Montreal Cognitive Assessment (MoCA), and equivalence dose of daily levodopa (LEDD). The generalized estimating equation (GEE) model with an exchangeable correlation structure was used to analyze the change in baseline and follow-up tracking and the disparity in change between these two groups. Results: The anosmia group was older and had a longer disease duration than the non-anosmia group. There was a significant decrease in UPSIT after follow-up in the non-anosmia group (ß = -3.62, p < 0.001) and a significant difference in the change between the two groups (group-by-time effect, ß = 4.03, p < 0.001). In the third part of the UPDRS motor scores, there was a tendency to increase the score in the non-anosmia group compared to the anosmia group (group-by-time effect, ß = -4.2, p < 0.038). There was no significant difference in the group-by-time effect for UPDRS total score, LEDD, BDI-II, and MoCA scores. Discussion: In conclusion, this study found that olfactory sensation may still regress in PD with a shorter disease course without anosmia, but it remains stable in the anosmia group. Such a decline in olfaction may not be related to cognitive status but may be associated with motor progression.

A new class of sky-blue-emitting Ir(III) phosphors assembled using fluorine-free pyridyl pyrimidine cyclometalates: application toward high-performance sky-blue- and white-emitting OLEDs.

Two pyrimidine chelates with the pyridin-2-yl group residing at either the 5- or 4-positions are synthesized. These chelates are then utilized in synthesizing of a new class of heteroleptic Ir(III) metal complexes, namely [Ir(b5ppm)2(fppz)] (1), [Ir(b5bpm)2(fppz)] (2), [Ir(b4bpm)2(fppz)] (3), and [Ir(b5bpm)(fppz)2] (4), for which the abbreviations b5ppm, b5bpm, b4bpm, and fppz represent chelates derived from 2-t-butyl-5-(pyridin-2-yl)pyrimidine, 2-t-butyl-5-(4-t-butylpyridin-2-yl)pyrimidine, 2-t-butyl-4-(4-t-butylpyridin-2-yl)pyrimidine, and 3-trifluoromethyl-5-(pyridin-2-yl) pyrazole, respectively. The single crystal X-ray structural analyses were executed on 1 to reveal their coordination arrangement around the Ir(III) metal element. The 5-substituted pyrimidine complexes 1, 2, and 4 exhibited the first emission peak wavelength (λmax) located in the range 452-457 nm with high quantum yields, whereas the emission of 3 with 4-substituted pyrimidine was red-shifted substantially to longer wavelength with λmax = 535 nm. These photophysical properties were discussed under the basis of computational approaches, particularly the relationship between emission color and the relative position of nitrogen atoms of pyrimidine fragment. For application, organic light-emitting diodes (OLEDs) were also fabricated using 2 and 4 as dopants, attaining the peak external quantum, luminance, and power efficiencies of 17.9% (38.0 cd/A and 35.8 lm/W) and 15.8% (30.6 cd/A and 24.8 lm/W), respectively. Combining sky blue-emitting 2 and red-emitting [Os(bpftz)2(PPh2Me)2] (5), the phosphorescent white OLEDs were demonstrated with stable pure-white emission at CIE coordinate of (0.33, 0.34), and peak luminance efficiency of 35.3 cd/A, power efficiency of 30.4 lm/W, and external quantum efficiency up to 17.3%.

Characterization of arecoline-induced effects on cytotoxicity in normal human gingival fibroblasts by global gene expression profiling.

Areca nut is the most widely used psychoactive substance and an important environmental risk factor for development of oral premalignant lesions and cancer. Arecoline, the major alkaloid of areca nut, has been known to cause cytotoxicity and genotoxicity in mammalian cells in vivo and in vitro and even contributes to carcinogenicity. However, the susceptible genes accounting for arecoline-induced damage in normal human oral cells are still lacking, which possibly involves in initial molecular damage via alternation of gene expression level on biological pathways. The present study was undertaken to characterize the toxic effects of arecoline in gene expression profiling on normal human gingival fibroblasts (HGF) using cDNA microarray and quantitative real-time reverse transcription PCR. The cytotoxicity of arecoline on HGF-1 cell line was elevated in a dose-dependent manner (p < 0.05) accompanied with distinct morphological change and formation of intracellular vacuoles were observed. At optimum concentration of arecoline determined from dose-response curve of the cytotoxicity, a large number of genes were significantly repressed than induced by arecoline in global gene expression profiling. Five induced- and seven repressed genes including glutathione synthetase were further validated, and their gene expression changes were increased in a dose-dependent manner in a concentration range of 50-150 microg/ml. In conclusion, we proposed a tentative model to explain arecoline-induced effects on contribution of oral pathogenesis. The findings identified that 12 susceptible genes can potentially serve as biomarkers of arecoline-induced damage in betel chewers.